[1]
2025. THE USE OF OXIDATIVE STRESS BIOMARKERS IN PREDICTING ONCOGENIC TRANSFORMATION OF LEUKOPLAKIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Modern American Journal of Medical and Health Sciences. 1, 2 (May 2025), 86–93.